"At the time of completion of dosing with either BIT225 or placebo with IFN/RBV, i.e. week 12 of the trial, both arms had very good response rates, with 96% of subjects in the BIT225 arm having more than 2 log reduction in virus levels, compared to 90% of the placebo arm."
"Patients with undetectable virus at this time are considered cured of HCV infection."
That is sensational news!!
Happy to hold on!
Ann: Independent review supports development of BIT225, page-4
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
